Editas Medicine, Inc. (EDIT)

3.23 +0.15 (+4.87%) USD  |  NASDAQ  |  Sep 04, 16:00
3.19 -0.04 (-1.24%) After-Hours: 20:00
More

Editas Medicine Cash and Short Term Investments (Annual) : 146.64M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 146.64M
December 31, 2024 269.91M
December 31, 2023 323.11M
December 31, 2022 344.27M
December 31, 2021 499.84M
December 31, 2020 402.11M
Date Value
December 31, 2019 457.14M
December 31, 2018 368.96M
December 31, 2017 329.14M
December 31, 2016 185.32M
December 31, 2015 143.50M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. 747.89M
Geron Corp. 359.80M
Halozyme Therapeutics, Inc. 142.82M
Novavax, Inc. 745.96M
AVITA Medical, Inc. 18.18M